Pharmaceuticals Market Research Reports & Industry Analysis
The global pharmaceutical industry is a vital part of the healthcare landscape—affecting everyone, from patients seeking treatment to healthcare providers looking for the latest advances in medicine. That's why MarketResearch.com offers a wide range of pharmaceutical reports, providing critical insights into market trends, industry challenges, and emerging opportunities.
What’s Inside Our Pharmaceutical Industry Reports
- We cover an extensive range of segments within the pharmaceutical industry, including biopharmaceuticals, clinical trials, dietary supplements, drug discovery, manufacturing & packaging, over-the-counter drugs, prescription drugs, research & development, vaccines, and more.
- Our research offers valuable information on the market landscape, key factors driving change, company and product profiles, and regulatory analysis.
- We also cover disruptive trends, such as gene editing, precision medicine, and artificial intelligence, ensuring our clients stay ahead of market changes.
MarketResearch.com: A Reliable Source for Critical Data
At MarketResearch.com, we understand the importance of reliable and comprehensive research. For over 20 years, we have been a leading company in the field of market research, bringing together reports from hundreds of leading firms in one place for convenient access.
View recent articles on this industry on our blog:
4 Blockbuster Drugs to Watch for Non-Small Lung Cancer (NSCLC)
Global Prefilled Syringes Market to Achieve Unprecedented Growth by 2035
Global Medical Aesthetic Market to Surge to $102.2 Billion by 2035
Cancer Biomarker Market Size to Reach $39.7 Billion by 2028
Additional articles on this industry
Pharmaceuticals Industry Research & Market Reports
-
Hybrid and Electric Vehicle Fuses
... is expected to reach US$10.3 Billion by 2030, growing at a CAGR of 24.4% over the analysis period 2023-2030. Hybrid Electric Vehicles (HEVs) Application, one of the segments analyzed in the report, is expected to ... Read More
-
Acute Coronary Syndrome - Market Insight, Epidemiology And Market Forecast - 2034
... US accounted for approximately 37% of the cases, EU4 and the UK countries accounted for around 54%, followed by Japan which represented nearly 9%. DelveInsight’s estimates indicate that in 2023, there were approximately 77,445 diagnosed ... Read More
-
Bronchiectasis - Market Insight, Epidemiology And Market Forecast - 2034
... the forecast period (2024–2034). This growth is primarily driven by rising diagnosed prevalent cases and the introduction of emerging therapies. According to DelveInsight's analysis, it is projected that approximately 41% of the Total Diagnosed Prevalent ... Read More
-
Chronic Heart Failure - Market Insight, Epidemiology And Market Forecast - 2034
... USD 12 billion which is further expected to rise at a CAGR of 2.8% by 2034. In 2023, the diagnosed prevalence of Atherosclerotic Cardiovascular Disease (ASCVD) was highest in the US among the 7MM, accounting ... Read More
-
Eosinophilic Esophagitis - Market Insight, Epidemiology And Market Forecast - 2034
... to grow with a significant CAGR during the forecast period. In 2023, the US accounted for the maximum share of the total market in the 7MM, i.e., approximately 66%. ITP is defined as a decrease ... Read More
-
Mild Cognitive Impairment - Market Insight, Epidemiology And Market Forecast - 2034
... virus infection in the 7MM is expected to increase, driven by increasing Incident population. DelveInsight’s analyst projects that the total Incident Cases of Parainfluenza Virus in 7MM were approximately 2,709,923 in 2023 and these cases ... Read More
-
Parkinson's Disease Market Insight, Epidemiology And Market Forecast - 2034
... the 7MM is expected to increase, driven by better diagnosis and the launch of emerging therapies. DelveInsight’s analysis estimates that among the total diagnosed prevalent cases of PDP in 7MM approximately 52% of cases were ... Read More
-
Pain Management Devices Market, Industry Trends and Global Forecasts, Till 2035
... during the forecast period, till 2035. Pain is a complex phenomenon involving unpleasant sensory experience, primarily associated with acute or chronic physical injury exacerbated by various psychological, biological, and social factors. The prevalence of pain ... Read More
-
Europe Medical Ceramics Market Report by Material Types (Bioinert, Bioactive, Bioresorbable, Piezo Ceramics), Application (Surgical Instruments, Plastic Surgery, Orthopedic application, Dental Application) Countries and Company 2024-2032
... ceramics that are employed in different healthcare applications and processes and are by and large bio compatible, strong and very durable. Being made from inorganic non-metallic compounds like alumina, zirconia and hydroxyapatite, these materials have ... Read More
-
Nutricosmetics Market
... 11.24 billion by 2030, exhibiting a CAGR of 7.36% during the forecast period of 2023-2030. The COVID-19 pandemic led to reduced consumption of beauty products as people stayed home and limited socialization. With many businesses ... Read More
-
Opioid Use Disorder (OUD) Market Size, Share, and Analysis, By Drug Class (Buprenorphine, Methadone, and Naltrexone), By Route of Administration (Oral, Sublingual, and Intravenous), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Region (North America, Europe, Asia-Pacific, and Rest of the World), And Regional Forecast 2024-2034
... Region (North America, Europe, Asia-Pacific, and Rest of the World), And Regional Forecast 2024-2034 Opioid Use Disorder (OUD) Market Size, Share, and Analysis, By Drug Class (Buprenorphine, Methadone, and Naltrexone), By Route of Administration (Oral, ... Read More
-
Spirulina Extracts
... at a CAGR of 9.3% over the analysis period 2023-2030. Arthrospira Platensis, one of the segments analyzed in the report, is expected to record a 10.0% CAGR and reach US$762.8 Million by the end of ... Read More
-
Europe Next Generation Sequencing Market Report by Products (Instruments, Reagents & Consumables, and Services), Application (Diagnostics, Agriculture and Animal Research, Drug Discovery, Personalized Medicine and Genetic Screening, and Others), Technology (Sequencing by Synthesis, Ion Semiconductor Sequencing, Single-Molecule Read Time Sequencing, Nanopore Sequencing, and Others), End-Users(Academic and Clinical Research Centers, Pharmaceutical and Biotechnology Companies, Hospitals and Clinics, and Others), Country and Company Analysis 2024-2032
... Sequencing, Single-Molecule Read Time Sequencing, Nanopore Sequencing, and Others), End-Users(Academic and Clinical Research Centers, Pharmaceutical and Biotechnology Companies, Hospitals and Clinics, and Others), Country and Company Analysis 2024-2032 Europe Next Generation Sequencing Market Outlooks Next ... Read More
-
Global Ranibizumab Drugs and Biosimilars Market Growth 2024-2030
... disease.Biosimilars of ranibizumab are biologic products that are highly similar to the original reference drug(ranibizumab)in terms of structure,efficacy,safety,and quality.These biosimilars aim to provide more affordable treatment options while maintaining therapeutic equivalence to the original biologic ... Read More
-
Digital Diabetes Management
... at a CAGR of 18.6% over the analysis period 2023-2030. Digital Diabetes Management Devices, one of the segments analyzed in the report, is expected to record a 18.5% CAGR and reach US$46.7 Billion by the ... Read More
-
In Vivo Toxicology
... at a CAGR of 6.3% over the analysis period 2023-2030. Consumables Component, one of the segments analyzed in the report, is expected to record a 7.3% CAGR and reach US$6.8 Billion by the end of ... Read More
-
Insulin Storage Devices
... at a CAGR of 7.3% over the analysis period 2023-2030. Battery Operated Devices, one of the segments analyzed in the report, is expected to record a 7.1% CAGR and reach US$996.0 Million by the end ... Read More
-
Herbal Supplements
... CAGR of 6.6% over the analysis period 2023-2030. Echinacea-sourced Supplements, one of the segments analyzed in the report, is expected to record a 6.9% CAGR and reach US$899.7 Million by the end of the analysis ... Read More
-
Human Insulin
... CAGR of 6.7% over the analysis period 2023-2030. HI Drugs, one of the segments analyzed in the report, is expected to record a 6.6% CAGR and reach US$70.6 Billion by the end of the analysis ... Read More
-
Respiratory Syncytial Virus (RSV) Therapeutics
... Billion by 2030, growing at a CAGR of 29.2% over the analysis period 2023-2030. Prophylaxis, one of the segments analyzed in the report, is expected to record a 28.5% CAGR and reach US$7.6 Billion by ... Read More
-
Thalassemia Treatment
... CAGR of 6.5% over the analysis period 2023-2030. Blood Transfusion Treatment, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$560.0 Million by the end of the ... Read More
-
Walnut
... 2.8% over the analysis period 2023-2030. Black Walnuts, one of the segments analyzed in the report, is expected to record a 2.3% CAGR and reach US$570.1 Million by the end of the analysis period. Growth ... Read More
-
Orthodontic Services
... CAGR of 11.5% over the analysis period 2023-2030. Removable Orthodontic Services, one of the segments analyzed in the report, is expected to record a 12.2% CAGR and reach US$7.7 Billion by the end of the ... Read More
-
Soft Tissue Allografts
... at a CAGR of 4.9% over the analysis period 2023-2030. Orthopedic Application, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$2.9 Billion by the end of ... Read More
-
Women's Health Rehabilitation Products
... 2030, growing at a CAGR of 1.2% over the analysis period 2023-2030. Orthopedic Rehabilitation Products, one of the segments analyzed in the report, is expected to record a 2.1% CAGR and reach US$731.9 Million by ... Read More
Research Assistance
